Mehran Moghaddam

Mehran Moghaddam

Company: OROX BioSciences Inc.

Job title: Chief Executive Officer


Inhalable Bifunctional sEH/COX-2 Inhibitors for Treatment of Asthma 1:30 pm

Developing inhalable bifunctional sEH/COX-2 small molecule inhibitors with novel mechanisms of action to treat Asthma Asthma affects over 300 million people worldwide and up to 55% of these patients experience recurrent episodes of bronchospasm despite long-acting beta-agonists plus high-dose inhaled or oral corticosteroids Chronic use of corticosteroids can lead to immune suppression, CVD risk, glaucoma,…Read more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.